NO962503L - Anvendelse av penoksyfyllin ved behandling av multippel sklerose - Google Patents

Anvendelse av penoksyfyllin ved behandling av multippel sklerose

Info

Publication number
NO962503L
NO962503L NO962503A NO962503A NO962503L NO 962503 L NO962503 L NO 962503L NO 962503 A NO962503 A NO 962503A NO 962503 A NO962503 A NO 962503A NO 962503 L NO962503 L NO 962503L
Authority
NO
Norway
Prior art keywords
treatment
multiple sclerosis
penoxyphylline
pentoxyphylline
dosage
Prior art date
Application number
NO962503A
Other languages
English (en)
Other versions
NO962503D0 (no
Inventor
Peter Rieckmann
Original Assignee
Rentschler Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel filed Critical Rentschler Arzneimittel
Publication of NO962503D0 publication Critical patent/NO962503D0/no
Publication of NO962503L publication Critical patent/NO962503L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører anvendelse av pentoksyfyllin ved behandling av den rykkvis forlepende eller kronisk fremskridende form for multippel sklerose i kombinasjon med et kortikosteroid. Doseringen av pentoksyfyllin er 0,01 til 6,0 g/dag, og doseringen av kortikoidet er 0,01 til 1000 mg/dag.
NO962503A 1993-12-16 1996-06-13 Anvendelse av penoksyfyllin ved behandling av multippel sklerose NO962503L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4343034A DE4343034C1 (de) 1993-12-16 1993-12-16 Verwendung von Pentoxifyllin zur Behandlung von Multipler Sklerose
PCT/EP1994/004188 WO1995016450A1 (de) 1993-12-16 1994-12-16 Verwendung von pentoxifyllin zur behandlung von multipler sklerose

Publications (2)

Publication Number Publication Date
NO962503D0 NO962503D0 (no) 1996-06-13
NO962503L true NO962503L (no) 1996-06-13

Family

ID=6505251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962503A NO962503L (no) 1993-12-16 1996-06-13 Anvendelse av penoksyfyllin ved behandling av multippel sklerose

Country Status (10)

Country Link
EP (1) EP0734262A1 (no)
JP (1) JPH09506603A (no)
CA (1) CA2176848A1 (no)
CZ (1) CZ170896A3 (no)
DE (1) DE4343034C1 (no)
FI (1) FI962473L (no)
NO (1) NO962503L (no)
PL (1) PL314588A1 (no)
SK (1) SK76696A3 (no)
WO (1) WO1995016450A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544768C1 (de) * 1995-11-30 1997-07-10 Rentschler Arzneimittel Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
WO2001087280A2 (de) * 2000-05-15 2001-11-22 Bayer Aktiengesellschaft Mittel zur schubtherapie von autoimmunerkrankungen
US20070105878A1 (en) * 2005-10-03 2007-05-10 Andrew Reaume Purine formulations and methods for managing disorders
CA2887682A1 (en) * 2012-10-09 2014-04-17 Biogen Idec Ma Inc. Combination therapies and uses for treatment of demyelinating disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307883A1 (en) * 1992-03-12 1993-09-23 Westarp Martin Egon Dr Med Use of anti-retroviral substances - to treat motor-neuronal diseases
US5763446A (en) * 1992-03-26 1998-06-09 University Of Southern California Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases

Also Published As

Publication number Publication date
NO962503D0 (no) 1996-06-13
FI962473A7 (fi) 1996-07-16
FI962473A0 (fi) 1996-06-14
FI962473L (fi) 1996-07-16
WO1995016450A1 (de) 1995-06-22
CA2176848A1 (en) 1995-06-22
PL314588A1 (en) 1996-09-16
JPH09506603A (ja) 1997-06-30
SK76696A3 (en) 1997-04-09
EP0734262A1 (de) 1996-10-02
DE4343034C1 (de) 1995-06-08
CZ170896A3 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
IL108007A (en) USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
EP0705100A4 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
DK0566709T5 (da) Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
DE69328771D1 (de) Verfahren zur hemmung der karzinogenese durch behandlung mit dehydroepiandrosteron und dessen analoge
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
TW362971B (en) Pharmaceutical composition and kit for treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M-phase specific anti
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
SE9603725D0 (sv) New teatment
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
MXPA04002565A (es) Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion.
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
NO931886L (no) Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO934832L (no) Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
UA27230C2 (uk) Похідні андростану, заміщені по 16-му положенню четвертинною амонієвою групою, для використання як нервово-м'язових блокаторів та фармацевтична композиція, що здатна викликати нервово-м'язову блокаду
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater